4//SEC Filing
Gupta Rishi 4
Accession 0000947871-23-000585
CIK 0001657312other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 6:06 PM ET
Size
11.6 KB
Accession
0000947871-23-000585
Insider Transaction Report
Form 4
Gupta Rishi
Director10% Owner
Transactions
- Sale
Ordinary Shares
2023-05-12$21.64/sh−43,200$934,848→ 4,137,491 total(indirect: See footnotes) - Sale
Ordinary Shares
2023-05-15$21.96/sh−14,400$316,224→ 4,123,091 total(indirect: See footnotes) - Sale
Ordinary Shares
2023-05-15$20.00/sh−345,313$6,906,260→ 3,777,778 total(indirect: See footnotes) - Sale
Ordinary Shares
2023-05-11$22.26/sh−80,000$1,780,800→ 4,180,691 total(indirect: See footnotes)
Footnotes (3)
- [F1]Consists of American Depository Shares ("ADSs") held of record by OrbiMed Private Investments VI, LP ("OPI VI"). Each ADS represents eight Ordinary Shares of the Issuer.
- [F2]These securities are held of record by OPI VI. OrbiMed Capital GP VI LLC ("OrbiMed GP") is the general partner of OPI VI, and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of OrbiMed GP. By virtue of such relationships, OrbiMed GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VI.
- [F3]Each of the Reporting Person, OrbiMed Advisors, and OrbiMed GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his or its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001537370
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 6:06 PM ET
- Size
- 11.6 KB